 |
treosulfan |
|---|---|
| Trade Name | |
| Orphan Indication | Conditioning treatment prior to hematopoietic stem cell transplantation (HSCT) in malignant and non-malignant diseases in adults and pediatric patients |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-08 00:00:00 |
| Sponsor | Medac GmbH;TheaterstraBe 6, 22880 Wedel; |
